Medical Care
Global CAR-NK Cell CDMO Service Market Research Report 2025
- Apr 07, 25
- ID: 171430
- Pages: 82
- Figures: 88
- Views: 37
The global market for CAR-NK Cell CDMO Service was valued at US$ 871 million in the year 2024 and is projected to reach a revised size of US$ 1186 million by 2031, growing at a CAGR of 5.2% during the forecast period.
CAR-NK cell CDMO service refers to a professional solution that provides a series of outsourcing services, including the design, preparation, production, and quality control of CAR-NK cells, for scientific research institutions, pharmaceutical companies, or medical institutions. CDMO (Contract Development and Manufacturing Organization) services cover multiple aspects, including the construction and optimization of cell lines, the development and validation of production processes, the preparation and testing of preclinical and clinical samples, as well as the release and quality control of final products. By providing professional CDMO services, clients can accelerate the research and development process of CAR-NK cell therapy, reduce development costs, improve research efficiency and quality, and thereby faster push CAR-NK cell therapy from the laboratory to the clinic.
North American market for CAR-NK Cell CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CAR-NK Cell CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CAR-NK Cell CDMO Service in Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CAR-NK Cell CDMO Service include Hillgene, Porton, Lotuslake Biomedical, Shenzhen Cell Valley, ProBio (GenScript Biotech), Charles River, SinoBiological, Beijing Cygenta Biotech, Promab, Creative-Biogene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CAR-NK Cell CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-NK Cell CDMO Service.
The CAR-NK Cell CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-NK Cell CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-NK Cell CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hillgene
Porton
Lotuslake Biomedical
Shenzhen Cell Valley
ProBio (GenScript Biotech)
Charles River
SinoBiological
Beijing Cygenta Biotech
Promab
Creative-Biogene
Creative-Biolabs
CD Formulaiton
Segment by Type
GMP CAR-NK Cell Production
Technology Transfer
Others
Segment by Application
Biopharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-NK Cell CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CAR-NK cell CDMO service refers to a professional solution that provides a series of outsourcing services, including the design, preparation, production, and quality control of CAR-NK cells, for scientific research institutions, pharmaceutical companies, or medical institutions. CDMO (Contract Development and Manufacturing Organization) services cover multiple aspects, including the construction and optimization of cell lines, the development and validation of production processes, the preparation and testing of preclinical and clinical samples, as well as the release and quality control of final products. By providing professional CDMO services, clients can accelerate the research and development process of CAR-NK cell therapy, reduce development costs, improve research efficiency and quality, and thereby faster push CAR-NK cell therapy from the laboratory to the clinic.
North American market for CAR-NK Cell CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CAR-NK Cell CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CAR-NK Cell CDMO Service in Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CAR-NK Cell CDMO Service include Hillgene, Porton, Lotuslake Biomedical, Shenzhen Cell Valley, ProBio (GenScript Biotech), Charles River, SinoBiological, Beijing Cygenta Biotech, Promab, Creative-Biogene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CAR-NK Cell CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-NK Cell CDMO Service.
The CAR-NK Cell CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-NK Cell CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-NK Cell CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hillgene
Porton
Lotuslake Biomedical
Shenzhen Cell Valley
ProBio (GenScript Biotech)
Charles River
SinoBiological
Beijing Cygenta Biotech
Promab
Creative-Biogene
Creative-Biolabs
CD Formulaiton
Segment by Type
GMP CAR-NK Cell Production
Technology Transfer
Others
Segment by Application
Biopharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-NK Cell CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-NK Cell CDMO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP CAR-NK Cell Production
1.2.3 Technology Transfer
1.2.4 Others
1.3 Market by Application
1.3.1 Global CAR-NK Cell CDMO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-NK Cell CDMO Service Market Perspective (2020-2031)
2.2 Global CAR-NK Cell CDMO Service Growth Trends by Region
2.2.1 Global CAR-NK Cell CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-NK Cell CDMO Service Historic Market Size by Region (2020-2025)
2.2.3 CAR-NK Cell CDMO Service Forecasted Market Size by Region (2026-2031)
2.3 CAR-NK Cell CDMO Service Market Dynamics
2.3.1 CAR-NK Cell CDMO Service Industry Trends
2.3.2 CAR-NK Cell CDMO Service Market Drivers
2.3.3 CAR-NK Cell CDMO Service Market Challenges
2.3.4 CAR-NK Cell CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-NK Cell CDMO Service Players by Revenue
3.1.1 Global Top CAR-NK Cell CDMO Service Players by Revenue (2020-2025)
3.1.2 Global CAR-NK Cell CDMO Service Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-NK Cell CDMO Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-NK Cell CDMO Service Revenue
3.4 Global CAR-NK Cell CDMO Service Market Concentration Ratio
3.4.1 Global CAR-NK Cell CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-NK Cell CDMO Service Revenue in 2024
3.5 Global Key Players of CAR-NK Cell CDMO Service Head office and Area Served
3.6 Global Key Players of CAR-NK Cell CDMO Service, Product and Application
3.7 Global Key Players of CAR-NK Cell CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-NK Cell CDMO Service Breakdown Data by Type
4.1 Global CAR-NK Cell CDMO Service Historic Market Size by Type (2020-2025)
4.2 Global CAR-NK Cell CDMO Service Forecasted Market Size by Type (2026-2031)
5 CAR-NK Cell CDMO Service Breakdown Data by Application
5.1 Global CAR-NK Cell CDMO Service Historic Market Size by Application (2020-2025)
5.2 Global CAR-NK Cell CDMO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-NK Cell CDMO Service Market Size (2020-2031)
6.2 North America CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
6.4 North America CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-NK Cell CDMO Service Market Size (2020-2031)
7.2 Europe CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
7.4 Europe CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-NK Cell CDMO Service Market Size (2020-2031)
8.2 Asia-Pacific CAR-NK Cell CDMO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR-NK Cell CDMO Service Market Size (2020-2031)
9.2 Latin America CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
9.4 Latin America CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-NK Cell CDMO Service Market Size (2020-2031)
10.2 Middle East & Africa CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hillgene
11.1.1 Hillgene Company Details
11.1.2 Hillgene Business Overview
11.1.3 Hillgene CAR-NK Cell CDMO Service Introduction
11.1.4 Hillgene Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.1.5 Hillgene Recent Development
11.2 Porton
11.2.1 Porton Company Details
11.2.2 Porton Business Overview
11.2.3 Porton CAR-NK Cell CDMO Service Introduction
11.2.4 Porton Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.2.5 Porton Recent Development
11.3 Lotuslake Biomedical
11.3.1 Lotuslake Biomedical Company Details
11.3.2 Lotuslake Biomedical Business Overview
11.3.3 Lotuslake Biomedical CAR-NK Cell CDMO Service Introduction
11.3.4 Lotuslake Biomedical Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.3.5 Lotuslake Biomedical Recent Development
11.4 Shenzhen Cell Valley
11.4.1 Shenzhen Cell Valley Company Details
11.4.2 Shenzhen Cell Valley Business Overview
11.4.3 Shenzhen Cell Valley CAR-NK Cell CDMO Service Introduction
11.4.4 Shenzhen Cell Valley Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.4.5 Shenzhen Cell Valley Recent Development
11.5 ProBio (GenScript Biotech)
11.5.1 ProBio (GenScript Biotech) Company Details
11.5.2 ProBio (GenScript Biotech) Business Overview
11.5.3 ProBio (GenScript Biotech) CAR-NK Cell CDMO Service Introduction
11.5.4 ProBio (GenScript Biotech) Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.5.5 ProBio (GenScript Biotech) Recent Development
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River CAR-NK Cell CDMO Service Introduction
11.6.4 Charles River Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.6.5 Charles River Recent Development
11.7 SinoBiological
11.7.1 SinoBiological Company Details
11.7.2 SinoBiological Business Overview
11.7.3 SinoBiological CAR-NK Cell CDMO Service Introduction
11.7.4 SinoBiological Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.7.5 SinoBiological Recent Development
11.8 Beijing Cygenta Biotech
11.8.1 Beijing Cygenta Biotech Company Details
11.8.2 Beijing Cygenta Biotech Business Overview
11.8.3 Beijing Cygenta Biotech CAR-NK Cell CDMO Service Introduction
11.8.4 Beijing Cygenta Biotech Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.8.5 Beijing Cygenta Biotech Recent Development
11.9 Promab
11.9.1 Promab Company Details
11.9.2 Promab Business Overview
11.9.3 Promab CAR-NK Cell CDMO Service Introduction
11.9.4 Promab Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.9.5 Promab Recent Development
11.10 Creative-Biogene
11.10.1 Creative-Biogene Company Details
11.10.2 Creative-Biogene Business Overview
11.10.3 Creative-Biogene CAR-NK Cell CDMO Service Introduction
11.10.4 Creative-Biogene Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.10.5 Creative-Biogene Recent Development
11.11 Creative-Biolabs
11.11.1 Creative-Biolabs Company Details
11.11.2 Creative-Biolabs Business Overview
11.11.3 Creative-Biolabs CAR-NK Cell CDMO Service Introduction
11.11.4 Creative-Biolabs Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.11.5 Creative-Biolabs Recent Development
11.12 CD Formulaiton
11.12.1 CD Formulaiton Company Details
11.12.2 CD Formulaiton Business Overview
11.12.3 CD Formulaiton CAR-NK Cell CDMO Service Introduction
11.12.4 CD Formulaiton Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.12.5 CD Formulaiton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-NK Cell CDMO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP CAR-NK Cell Production
1.2.3 Technology Transfer
1.2.4 Others
1.3 Market by Application
1.3.1 Global CAR-NK Cell CDMO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-NK Cell CDMO Service Market Perspective (2020-2031)
2.2 Global CAR-NK Cell CDMO Service Growth Trends by Region
2.2.1 Global CAR-NK Cell CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-NK Cell CDMO Service Historic Market Size by Region (2020-2025)
2.2.3 CAR-NK Cell CDMO Service Forecasted Market Size by Region (2026-2031)
2.3 CAR-NK Cell CDMO Service Market Dynamics
2.3.1 CAR-NK Cell CDMO Service Industry Trends
2.3.2 CAR-NK Cell CDMO Service Market Drivers
2.3.3 CAR-NK Cell CDMO Service Market Challenges
2.3.4 CAR-NK Cell CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-NK Cell CDMO Service Players by Revenue
3.1.1 Global Top CAR-NK Cell CDMO Service Players by Revenue (2020-2025)
3.1.2 Global CAR-NK Cell CDMO Service Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-NK Cell CDMO Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-NK Cell CDMO Service Revenue
3.4 Global CAR-NK Cell CDMO Service Market Concentration Ratio
3.4.1 Global CAR-NK Cell CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-NK Cell CDMO Service Revenue in 2024
3.5 Global Key Players of CAR-NK Cell CDMO Service Head office and Area Served
3.6 Global Key Players of CAR-NK Cell CDMO Service, Product and Application
3.7 Global Key Players of CAR-NK Cell CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-NK Cell CDMO Service Breakdown Data by Type
4.1 Global CAR-NK Cell CDMO Service Historic Market Size by Type (2020-2025)
4.2 Global CAR-NK Cell CDMO Service Forecasted Market Size by Type (2026-2031)
5 CAR-NK Cell CDMO Service Breakdown Data by Application
5.1 Global CAR-NK Cell CDMO Service Historic Market Size by Application (2020-2025)
5.2 Global CAR-NK Cell CDMO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-NK Cell CDMO Service Market Size (2020-2031)
6.2 North America CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
6.4 North America CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-NK Cell CDMO Service Market Size (2020-2031)
7.2 Europe CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
7.4 Europe CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-NK Cell CDMO Service Market Size (2020-2031)
8.2 Asia-Pacific CAR-NK Cell CDMO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR-NK Cell CDMO Service Market Size (2020-2031)
9.2 Latin America CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
9.4 Latin America CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-NK Cell CDMO Service Market Size (2020-2031)
10.2 Middle East & Africa CAR-NK Cell CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hillgene
11.1.1 Hillgene Company Details
11.1.2 Hillgene Business Overview
11.1.3 Hillgene CAR-NK Cell CDMO Service Introduction
11.1.4 Hillgene Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.1.5 Hillgene Recent Development
11.2 Porton
11.2.1 Porton Company Details
11.2.2 Porton Business Overview
11.2.3 Porton CAR-NK Cell CDMO Service Introduction
11.2.4 Porton Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.2.5 Porton Recent Development
11.3 Lotuslake Biomedical
11.3.1 Lotuslake Biomedical Company Details
11.3.2 Lotuslake Biomedical Business Overview
11.3.3 Lotuslake Biomedical CAR-NK Cell CDMO Service Introduction
11.3.4 Lotuslake Biomedical Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.3.5 Lotuslake Biomedical Recent Development
11.4 Shenzhen Cell Valley
11.4.1 Shenzhen Cell Valley Company Details
11.4.2 Shenzhen Cell Valley Business Overview
11.4.3 Shenzhen Cell Valley CAR-NK Cell CDMO Service Introduction
11.4.4 Shenzhen Cell Valley Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.4.5 Shenzhen Cell Valley Recent Development
11.5 ProBio (GenScript Biotech)
11.5.1 ProBio (GenScript Biotech) Company Details
11.5.2 ProBio (GenScript Biotech) Business Overview
11.5.3 ProBio (GenScript Biotech) CAR-NK Cell CDMO Service Introduction
11.5.4 ProBio (GenScript Biotech) Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.5.5 ProBio (GenScript Biotech) Recent Development
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River CAR-NK Cell CDMO Service Introduction
11.6.4 Charles River Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.6.5 Charles River Recent Development
11.7 SinoBiological
11.7.1 SinoBiological Company Details
11.7.2 SinoBiological Business Overview
11.7.3 SinoBiological CAR-NK Cell CDMO Service Introduction
11.7.4 SinoBiological Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.7.5 SinoBiological Recent Development
11.8 Beijing Cygenta Biotech
11.8.1 Beijing Cygenta Biotech Company Details
11.8.2 Beijing Cygenta Biotech Business Overview
11.8.3 Beijing Cygenta Biotech CAR-NK Cell CDMO Service Introduction
11.8.4 Beijing Cygenta Biotech Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.8.5 Beijing Cygenta Biotech Recent Development
11.9 Promab
11.9.1 Promab Company Details
11.9.2 Promab Business Overview
11.9.3 Promab CAR-NK Cell CDMO Service Introduction
11.9.4 Promab Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.9.5 Promab Recent Development
11.10 Creative-Biogene
11.10.1 Creative-Biogene Company Details
11.10.2 Creative-Biogene Business Overview
11.10.3 Creative-Biogene CAR-NK Cell CDMO Service Introduction
11.10.4 Creative-Biogene Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.10.5 Creative-Biogene Recent Development
11.11 Creative-Biolabs
11.11.1 Creative-Biolabs Company Details
11.11.2 Creative-Biolabs Business Overview
11.11.3 Creative-Biolabs CAR-NK Cell CDMO Service Introduction
11.11.4 Creative-Biolabs Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.11.5 Creative-Biolabs Recent Development
11.12 CD Formulaiton
11.12.1 CD Formulaiton Company Details
11.12.2 CD Formulaiton Business Overview
11.12.3 CD Formulaiton CAR-NK Cell CDMO Service Introduction
11.12.4 CD Formulaiton Revenue in CAR-NK Cell CDMO Service Business (2020-2025)
11.12.5 CD Formulaiton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CAR-NK Cell CDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of GMP CAR-NK Cell Production
Table 3. Key Players of Technology Transfer
Table 4. Key Players of Others
Table 5. Global CAR-NK Cell CDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CAR-NK Cell CDMO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CAR-NK Cell CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global CAR-NK Cell CDMO Service Market Share by Region (2020-2025)
Table 9. Global CAR-NK Cell CDMO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global CAR-NK Cell CDMO Service Market Share by Region (2026-2031)
Table 11. CAR-NK Cell CDMO Service Market Trends
Table 12. CAR-NK Cell CDMO Service Market Drivers
Table 13. CAR-NK Cell CDMO Service Market Challenges
Table 14. CAR-NK Cell CDMO Service Market Restraints
Table 15. Global CAR-NK Cell CDMO Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global CAR-NK Cell CDMO Service Market Share by Players (2020-2025)
Table 17. Global Top CAR-NK Cell CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-NK Cell CDMO Service as of 2024)
Table 18. Ranking of Global Top CAR-NK Cell CDMO Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by CAR-NK Cell CDMO Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of CAR-NK Cell CDMO Service, Headquarters and Area Served
Table 21. Global Key Players of CAR-NK Cell CDMO Service, Product and Application
Table 22. Global Key Players of CAR-NK Cell CDMO Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-NK Cell CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global CAR-NK Cell CDMO Service Revenue Market Share by Type (2020-2025)
Table 26. Global CAR-NK Cell CDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global CAR-NK Cell CDMO Service Revenue Market Share by Type (2026-2031)
Table 28. Global CAR-NK Cell CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global CAR-NK Cell CDMO Service Revenue Market Share by Application (2020-2025)
Table 30. Global CAR-NK Cell CDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global CAR-NK Cell CDMO Service Revenue Market Share by Application (2026-2031)
Table 32. North America CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific CAR-NK Cell CDMO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. Hillgene Company Details
Table 48. Hillgene Business Overview
Table 49. Hillgene CAR-NK Cell CDMO Service Product
Table 50. Hillgene Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 51. Hillgene Recent Development
Table 52. Porton Company Details
Table 53. Porton Business Overview
Table 54. Porton CAR-NK Cell CDMO Service Product
Table 55. Porton Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 56. Porton Recent Development
Table 57. Lotuslake Biomedical Company Details
Table 58. Lotuslake Biomedical Business Overview
Table 59. Lotuslake Biomedical CAR-NK Cell CDMO Service Product
Table 60. Lotuslake Biomedical Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 61. Lotuslake Biomedical Recent Development
Table 62. Shenzhen Cell Valley Company Details
Table 63. Shenzhen Cell Valley Business Overview
Table 64. Shenzhen Cell Valley CAR-NK Cell CDMO Service Product
Table 65. Shenzhen Cell Valley Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 66. Shenzhen Cell Valley Recent Development
Table 67. ProBio (GenScript Biotech) Company Details
Table 68. ProBio (GenScript Biotech) Business Overview
Table 69. ProBio (GenScript Biotech) CAR-NK Cell CDMO Service Product
Table 70. ProBio (GenScript Biotech) Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 71. ProBio (GenScript Biotech) Recent Development
Table 72. Charles River Company Details
Table 73. Charles River Business Overview
Table 74. Charles River CAR-NK Cell CDMO Service Product
Table 75. Charles River Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 76. Charles River Recent Development
Table 77. SinoBiological Company Details
Table 78. SinoBiological Business Overview
Table 79. SinoBiological CAR-NK Cell CDMO Service Product
Table 80. SinoBiological Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 81. SinoBiological Recent Development
Table 82. Beijing Cygenta Biotech Company Details
Table 83. Beijing Cygenta Biotech Business Overview
Table 84. Beijing Cygenta Biotech CAR-NK Cell CDMO Service Product
Table 85. Beijing Cygenta Biotech Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 86. Beijing Cygenta Biotech Recent Development
Table 87. Promab Company Details
Table 88. Promab Business Overview
Table 89. Promab CAR-NK Cell CDMO Service Product
Table 90. Promab Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 91. Promab Recent Development
Table 92. Creative-Biogene Company Details
Table 93. Creative-Biogene Business Overview
Table 94. Creative-Biogene CAR-NK Cell CDMO Service Product
Table 95. Creative-Biogene Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 96. Creative-Biogene Recent Development
Table 97. Creative-Biolabs Company Details
Table 98. Creative-Biolabs Business Overview
Table 99. Creative-Biolabs CAR-NK Cell CDMO Service Product
Table 100. Creative-Biolabs Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 101. Creative-Biolabs Recent Development
Table 102. CD Formulaiton Company Details
Table 103. CD Formulaiton Business Overview
Table 104. CD Formulaiton CAR-NK Cell CDMO Service Product
Table 105. CD Formulaiton Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 106. CD Formulaiton Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. CAR-NK Cell CDMO Service Picture
Figure 2. Global CAR-NK Cell CDMO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-NK Cell CDMO Service Market Share by Type: 2024 VS 2031
Figure 4. GMP CAR-NK Cell Production Features
Figure 5. Technology Transfer Features
Figure 6. Others Features
Figure 7. Global CAR-NK Cell CDMO Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global CAR-NK Cell CDMO Service Market Share by Application: 2024 VS 2031
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. CAR-NK Cell CDMO Service Report Years Considered
Figure 13. Global CAR-NK Cell CDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global CAR-NK Cell CDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CAR-NK Cell CDMO Service Market Share by Region: 2024 VS 2031
Figure 16. Global CAR-NK Cell CDMO Service Market Share by Players in 2024
Figure 17. Global CAR-NK Cell CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by CAR-NK Cell CDMO Service Revenue in 2024
Figure 19. North America CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 21. United States CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 25. Germany CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific CAR-NK Cell CDMO Service Market Share by Region (2020-2031)
Figure 33. China CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 41. Mexico CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 45. Turkey CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Hillgene Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 49. Porton Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 50. Lotuslake Biomedical Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 51. Shenzhen Cell Valley Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 52. ProBio (GenScript Biotech) Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 53. Charles River Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 54. SinoBiological Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 55. Beijing Cygenta Biotech Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 56. Promab Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 57. Creative-Biogene Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 58. Creative-Biolabs Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 59. CD Formulaiton Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global CAR-NK Cell CDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of GMP CAR-NK Cell Production
Table 3. Key Players of Technology Transfer
Table 4. Key Players of Others
Table 5. Global CAR-NK Cell CDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CAR-NK Cell CDMO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CAR-NK Cell CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global CAR-NK Cell CDMO Service Market Share by Region (2020-2025)
Table 9. Global CAR-NK Cell CDMO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global CAR-NK Cell CDMO Service Market Share by Region (2026-2031)
Table 11. CAR-NK Cell CDMO Service Market Trends
Table 12. CAR-NK Cell CDMO Service Market Drivers
Table 13. CAR-NK Cell CDMO Service Market Challenges
Table 14. CAR-NK Cell CDMO Service Market Restraints
Table 15. Global CAR-NK Cell CDMO Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global CAR-NK Cell CDMO Service Market Share by Players (2020-2025)
Table 17. Global Top CAR-NK Cell CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-NK Cell CDMO Service as of 2024)
Table 18. Ranking of Global Top CAR-NK Cell CDMO Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by CAR-NK Cell CDMO Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of CAR-NK Cell CDMO Service, Headquarters and Area Served
Table 21. Global Key Players of CAR-NK Cell CDMO Service, Product and Application
Table 22. Global Key Players of CAR-NK Cell CDMO Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-NK Cell CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global CAR-NK Cell CDMO Service Revenue Market Share by Type (2020-2025)
Table 26. Global CAR-NK Cell CDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global CAR-NK Cell CDMO Service Revenue Market Share by Type (2026-2031)
Table 28. Global CAR-NK Cell CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global CAR-NK Cell CDMO Service Revenue Market Share by Application (2020-2025)
Table 30. Global CAR-NK Cell CDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global CAR-NK Cell CDMO Service Revenue Market Share by Application (2026-2031)
Table 32. North America CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific CAR-NK Cell CDMO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific CAR-NK Cell CDMO Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa CAR-NK Cell CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa CAR-NK Cell CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. Hillgene Company Details
Table 48. Hillgene Business Overview
Table 49. Hillgene CAR-NK Cell CDMO Service Product
Table 50. Hillgene Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 51. Hillgene Recent Development
Table 52. Porton Company Details
Table 53. Porton Business Overview
Table 54. Porton CAR-NK Cell CDMO Service Product
Table 55. Porton Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 56. Porton Recent Development
Table 57. Lotuslake Biomedical Company Details
Table 58. Lotuslake Biomedical Business Overview
Table 59. Lotuslake Biomedical CAR-NK Cell CDMO Service Product
Table 60. Lotuslake Biomedical Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 61. Lotuslake Biomedical Recent Development
Table 62. Shenzhen Cell Valley Company Details
Table 63. Shenzhen Cell Valley Business Overview
Table 64. Shenzhen Cell Valley CAR-NK Cell CDMO Service Product
Table 65. Shenzhen Cell Valley Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 66. Shenzhen Cell Valley Recent Development
Table 67. ProBio (GenScript Biotech) Company Details
Table 68. ProBio (GenScript Biotech) Business Overview
Table 69. ProBio (GenScript Biotech) CAR-NK Cell CDMO Service Product
Table 70. ProBio (GenScript Biotech) Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 71. ProBio (GenScript Biotech) Recent Development
Table 72. Charles River Company Details
Table 73. Charles River Business Overview
Table 74. Charles River CAR-NK Cell CDMO Service Product
Table 75. Charles River Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 76. Charles River Recent Development
Table 77. SinoBiological Company Details
Table 78. SinoBiological Business Overview
Table 79. SinoBiological CAR-NK Cell CDMO Service Product
Table 80. SinoBiological Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 81. SinoBiological Recent Development
Table 82. Beijing Cygenta Biotech Company Details
Table 83. Beijing Cygenta Biotech Business Overview
Table 84. Beijing Cygenta Biotech CAR-NK Cell CDMO Service Product
Table 85. Beijing Cygenta Biotech Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 86. Beijing Cygenta Biotech Recent Development
Table 87. Promab Company Details
Table 88. Promab Business Overview
Table 89. Promab CAR-NK Cell CDMO Service Product
Table 90. Promab Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 91. Promab Recent Development
Table 92. Creative-Biogene Company Details
Table 93. Creative-Biogene Business Overview
Table 94. Creative-Biogene CAR-NK Cell CDMO Service Product
Table 95. Creative-Biogene Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 96. Creative-Biogene Recent Development
Table 97. Creative-Biolabs Company Details
Table 98. Creative-Biolabs Business Overview
Table 99. Creative-Biolabs CAR-NK Cell CDMO Service Product
Table 100. Creative-Biolabs Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 101. Creative-Biolabs Recent Development
Table 102. CD Formulaiton Company Details
Table 103. CD Formulaiton Business Overview
Table 104. CD Formulaiton CAR-NK Cell CDMO Service Product
Table 105. CD Formulaiton Revenue in CAR-NK Cell CDMO Service Business (2020-2025) & (US$ Million)
Table 106. CD Formulaiton Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. CAR-NK Cell CDMO Service Picture
Figure 2. Global CAR-NK Cell CDMO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-NK Cell CDMO Service Market Share by Type: 2024 VS 2031
Figure 4. GMP CAR-NK Cell Production Features
Figure 5. Technology Transfer Features
Figure 6. Others Features
Figure 7. Global CAR-NK Cell CDMO Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global CAR-NK Cell CDMO Service Market Share by Application: 2024 VS 2031
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. CAR-NK Cell CDMO Service Report Years Considered
Figure 13. Global CAR-NK Cell CDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global CAR-NK Cell CDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CAR-NK Cell CDMO Service Market Share by Region: 2024 VS 2031
Figure 16. Global CAR-NK Cell CDMO Service Market Share by Players in 2024
Figure 17. Global CAR-NK Cell CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by CAR-NK Cell CDMO Service Revenue in 2024
Figure 19. North America CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 21. United States CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 25. Germany CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific CAR-NK Cell CDMO Service Market Share by Region (2020-2031)
Figure 33. China CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 41. Mexico CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa CAR-NK Cell CDMO Service Market Share by Country (2020-2031)
Figure 45. Turkey CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE CAR-NK Cell CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Hillgene Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 49. Porton Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 50. Lotuslake Biomedical Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 51. Shenzhen Cell Valley Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 52. ProBio (GenScript Biotech) Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 53. Charles River Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 54. SinoBiological Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 55. Beijing Cygenta Biotech Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 56. Promab Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 57. Creative-Biogene Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 58. Creative-Biolabs Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 59. CD Formulaiton Revenue Growth Rate in CAR-NK Cell CDMO Service Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232